K200409

Substantially Equivalent

Pelvital System

Applicant: Pelvital USA, Inc.
Product code: HIR
Advisory panel: Obstetrics/Gynecology
Date received: 2020-02-19
Decision date: 2020-07-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Minneapolis, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.